Clinical Trials

664 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT04924062 2026-04-15

KEYNOTE-966

158 enrolled 19 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT02311959 2026-04-14

MAPAM-01

450 enrolled

Breast

Breast Neoplasms, Carcinoma in Situ

NCT03625531 2026-04-14

A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS

1,103 enrolled

Polycystic Ovary Syndrome

NCT02771405 2026-04-13

FRI-STC

150 enrolled

Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT03555422 2026-04-13

ENGOT-EN5

263 enrolled

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT03957590 2026-04-13

A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma

370 enrolled 17 charts

Esophageal Squamous Cell Carcinoma

NCT05377554 2026-04-13

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

154 enrolled

Tumor-Agnostic

Neoplasms

NCT04540211 2026-04-09

SKYSCRAPER-08

461 enrolled 24 charts

Esophageal Neoplasms

NCT06159790 2026-04-09

A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

218 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01503632 2026-04-08

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

LymphoidOther hematologic neoplasm

570 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03570892 2026-04-08

BELINDA

330 enrolled 10 charts

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04102020 2026-04-08

VIALE-M

Other hematologic neoplasm

112 enrolled 13 charts

Leukemia, Myeloid, Acute

NCT04231448 2026-04-08

DEB

423 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05375461 2026-04-08

TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail

293 enrolled

Breast

HR-positive,HER2-negative in Advanced Breast Cancer

NCT00430365 2026-04-06

IFM2005-02

614 enrolled

Plasma cell

Neoplasms, Plasma Cell

NCT01191060 2026-04-06

IFM/DFCI2009

700 enrolled

Plasma cell

Disease Progression, Neoplasms, Plasma Cell

NCT01226394 2026-04-06

ProphyloCHIP

150 enrolled

Krukenberg Tumor, Peritoneal Neoplasms

NCT03903562 2026-04-06

V503-024

1,990 enrolled 42 charts

Papillomavirus Infections

NCT00116454 2026-04-03

Lipiocis

73 enrolled

Hepatitis, Alcoholic, Hepatitis, Viral, Human, Carcinoma, Hepatocellular

NCT04256421 2026-04-03

SKYSCRAPER-02

490 enrolled 33 charts

Small Cell Lung Carcinoma

NCT00931645 2026-04-02

Auto-LLC 2001

LymphoidOther hematologic neoplasm

241 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02343601 2026-04-02

PANEX3

160 enrolled

Crohn Disease, Colorectal Neoplasms

NCT02044354 2026-04-01

CABA-DOC

195 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT02435953 2026-03-31

TORCH

241 enrolled

Carcinoma, Hepatocellular

NCT03401060 2026-03-31

DenosuMast

24 enrolled

Myeloid

Osteoporosis, Mastocytosis, Systemic

NCT03979014 2026-03-31

NOVEL

1,099 enrolled

Uterine Cervical Neoplasms, Neoplasms

NCT00003140 2026-03-27

Letrozole After Tamoxifen in Treating Women With Breast Cancer

5,187 enrolled

Breast

Breast Neoplasms

NCT04199104 2026-03-27

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)

511 enrolled 20 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05907122 2026-03-27

A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

256 enrolled

Dermatologic

Melanoma

NCT06471361 2026-03-27

A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

31 enrolled 11 charts

Myasthenia Gravis

NCT06135415 2026-03-25

TirbAKare

DermatologicOther neoplasm

280 enrolled

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT04003636 2026-03-24

KEYNOTE-966

1,069 enrolled 19 charts 2 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04472598 2026-03-23

TRANSFORM-1

252 enrolled 17 charts

Myeloid

Neoplasms, Primary Myelofibrosis

NCT03517449 2026-03-19

MK-3475-775

827 enrolled 34 charts 2 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT04720716 2026-03-19

A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC

344 enrolled

Carcinoma, Hepatocellular

NCT02973789 2026-03-18

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

291 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT04948333 2026-03-18

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP